Under construction – not a live service
Sign in
Taking people in ItalyNo phase

Registry following heart patients with implanted devices monitored remotely

Collects data from people with heart rhythm devices sent through remote monitoring.

Plain-language title generated from the registry record
Registry title: Multicenter Evaluation of Patients Using LATITUDE Monitoring System

Key facts

Where
Ferrara, Naples, and Roma, ItalySee the 3 sites

Where in Italy

  • Azienda Ospedaliero Universitaria di FerraraFerrara, ItalyTaking people
  • Policlinico Federico IINaples, ItalyTaking people
  • Ospedale "G.B. Grassi"Roma, ItalyTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
University Hospital of Ferrara
Trial code
NCT06311149
Record updated
12 August 2024
Original description
The Multitude is a registry of patients who receive commercially available CIEDs that remotely communicate through the LATITUDE monitoring system and transfer data to a central database.Read full original descriptionShow less

Multicenter Evaluation of Patients Using LATITUDE Monitoring System: Multitude Study

The Multitude is a registry of patients who receive commercially available CIEDs that remotely communicate through the LATITUDE monitoring system and transfer data to a central database.

The registry is designed to constitute a shared environment for the collection, management, analysis and reporting of clinical and diagnostic data, adopted by a network of European scientifically-motivated physicians who use rhythm management diagnostic and therapeutic solutions from Boston Scientific in their clinical practice.

The Multitude study will facilitate the sharing of scientific proposals within a large network of researchers, and it will allow researchers to record the experience with medical devices throughout the device and patient lifecycle.

Inclusion: Subject is willing and capable of providing informed consent to collect/store/process personal health information by the sponsor or such consent is provided by a legally designated representative, if required by local law or regulation; Subject is:; prospectively scheduled for receiving a device monitored through the LATITUDE monitoring system; retrospectively enrolled after having received a device monitored through the LATITUDE monitoring system.

Exclusion: Subject foreseen not to be followed at the enrolling center for at least 1 year after having received the device; Subject is receiving a device that is not approved for commercial use at the time of procedure.

ClinicalTrials.gov NCT06311149